Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy

The combination of chemotherapeutic drug paclitaxel (PTX) and VEGF siRNA could inhibit cancer development with synergistic efficacy. However, efficient and safe delivery systems with high encapsulation efficiency of PTX and a long-time release of drugs are urgently needed. In this study, novel nanop...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Deliv
Autors principals: Zhang, Chuanmin, Zhao, Yinan, Zhang, Enxia, Jiang, Meilin, Zhi, Defu, Chen, Huiying, Cui, Shaohui, Zhen, Yuhong, Cui, Jingnan, Zhang, Shubiao
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594708/
https://ncbi.nlm.nih.gov/pubmed/33096948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2020.1827085
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars